Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 2Lymphoid 2Breast 2Plasma cell 1Other hematologic neoplasm 1Other 1Genitourinary 1Gastrointestinal 1

Conditions

Peripheral Nervous System Diseases 1Gastrointestinal Neoplasms 1Breast Neoplasms 1

Interventions

Oxaliplatin 300Fluorouracil 273Gemcitabine 238Bevacizumab 235Leucovorin 212Capecitabine 207pembrolizumab 201Irinotecan 159Nivolumab 158Cisplatin 151Specimen Handling 143Magnetic Resonance Spectroscopy 129130-nm albumin-bound paclitaxel 118Paclitaxel 109durvalumab 106Cetuximab 104Radiotherapy 99Drug Therapy 94atezolizumab 93Biopsy 92tislelizumab 81Albumin-Bound Paclitaxel 81Taxes 75lenvatinib 67Folfox protocol 67Carboplatin 66regorafenib 61Blood Specimen Collection 60sintilimab 54Ipilimumab 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Massage × Gastrointestinal × 1 year × Clear all
NCT02221700 2026-03-09

Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies

M.D. Anderson Cancer Center

Phase NA Active not recruiting
90 enrolled
BreastGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡